duplication

Digital

At the heart of every pharma company lies a big problem: medical affairs and commercial teams are independently creating the same content.

News

Curium's copycat version of Novartis GEP-NET therapy Lutathera, Bexlutry, is the first radioligand equivalent (RLE) to be approved by the FDA.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.